BioSpace News Archive

Capillary Biomedical, Inc. (CapBio) has announced that it has received a $1.5 million program-related investment in the form of a loan from The Leona M. and Harry B. Helmsley Charitable Trust (Helmsley). The use of funds includes clinical studies of CapBio’s

Micro-Tech Endoscopy recently launched the PinPoint Injection Needle, showcasing Micro-Tech’s continued commitment to make its mark on the medical device industry, working closely with doctors dedicated to innovation, and bringing high quality devices to market at unprecedented speed.

Lumenix is pleased to announce its advancement into artificial intelligence through the acquisition of the SIMPedsTM Artificially Intelligent Monitoring System (AIMS) prototype from Boston Children’s Hospital (BCH) completed in March 2020

Today, the U.S. Food and Drug Administration issued a warning letter to Battelle Memorial Institute for failure to comply with regulatory requirements for medical device reporting as specified in the Emergency Use Authorization (EUA) for the Battelle Critical Care Decontamination System. “It is critical that manufacturers h

October is ADHD Awareness Month, and retired NFL linebacker J.T. Thomas wants people to know that it is okay to get help for the treatment of attention deficit hyperactivity disorder (ADHD).

ILC Therapeutics , a Scottish biotech company, has announced that its unique synthetic Interferon called Alfacyte™ is fifteen to twenty times more effective at preventing the spread of SARS-CoV-2 (the virus which causes COVID-19) in cell culture than other commercially-available Interferons such as Interferon alpha 2 and Interferon beta 1a. COVID-19 tries to slow down the body’s innate Interferon response to viral infe

Veeva Systems (NYSE: VEEV) today announced the first two applications built on the Veeva Clinical Network, the industry’s only solution that links sponsors, clinical research sites, and patients for paperless, patient-centric trials. Veeva Site Connect connects sponsors and clinical research sites

Riverview Health Emergency Room & Urgent Care will open its third combined, freestanding emergency room and urgent care facility in Hamilton County in West Carmel/Zionsville on Monday, Oct. 19 at 7 a.m.

In preclinical studies, Salicyn-30, a small molecule, demonstrated potent in-vitro viral load reduction of 3-4 log in SARS-CoV-2 infection model in normal healthy VERO E6 cells. Salicyn-30 displays a novel mechanism of inhibition of SARS-CoV-2, with potential additive benefits when used in a multi-modal therapy approach. Salicyn-30 can potentially be administered orally alone and will be tested in combination with Sorrento’s potent STI-1499 and affinity matured STI-2020 neutralizing antibo

On September 23rd, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for the first serology (antibody) Point-Of-Care (POC) test for COVID-19.